Kathleen Smith-Gomez, FNP-BC
NPI 1336844166 · Nurse Practitioner · Lower Gwynedd, PA
Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1336844166
- Entity type
- Individual
- Primary specialty
- Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
- Credential
- FNP-BC
- Sex
- Female
- Sole proprietor
- No
- License
- SP027072 (PA)
Specialties & taxonomies
Physician Assistants & Advanced Practice Nursing Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
3 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
1,315 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 319 | $5 |
| Residence Visit for Established Patient With Straightforward Medical Decision Making, Per Day, If Using Time, at Least 15 Minutes99347 | 202 | $37 |
| Residence Visit for Established Patient With Low Level of Medical Decision Making, Per Day, If Using Time, at Least 30 Minutes99348 | 170 | $62 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 164 | $39 |
| Destruction of Skin Growth, 1-14 Growths17110 | 137 | $90 |
| Residence Visit for New Patient With Low Level of Medical Decision Making, Per Day, If Using Time, at Least 30 Minutes |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 7 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Triamcinolone Acetonide | 71 | 51 |
| Ketoconazole | 60 | 42 |
| Mupirocin | 24 | 20 |
| Hydrocortisone | 24 | 16 |
| Ammonium Lactate | 22 | 17 |
| Metronidazole | 11 | — |
| Betamethasone Dipropionate | 11 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Practice location
Mailing address
Registry dates
- Enumerated
- 2023-04-03
- Last updated
- 2023-06-20
- Certified
- 2023-06-20
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.